FP7Индивидуална стипендия2014–2016

MemSense · Microcavity Array Supported Lipid Bilayers; Biomimetic Test Beds for Drug–Membrane Interactions

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2014-03-04 → 2016-03-03
Финансиране от ЕС
183 505 €
Участници
1
Схема
MC-IEF

Линиите свързват координатора с партньорите.

Накратко на български

Наноструктурирани масиви от микрокухини се използват за изследване на това как лекарствата преминават през липидните мембрани на клетките. Това помага за по-бързото и евтино избиране на подходящи цели при разработването на нови медикаменти.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Microcavity Array Supported Lipid Bilayers; Biomimetic Test Beds for Drug–Membrane Interactions

Project No: 624318 Project Acronym: MemSense Project Full Name: Microcavity Array Supported Lipid Bilayers; Biomimetic Test Beds for Drug Membrane Interactions 1. Publishable Summary The key goals of the research project were; development of state of the art, optimised plasmonically directed nanostructured arrays which will lead to the production of a novel drug-membrane permeability assay which provides a diffusion coefficient value for a range of drugs interacting with different membranes. Ultimately the aim was to produce and provide a platform/assay for assessing membrane permeability which can be utilised in drug discovery to facilitate the selection of appropriate targets earlier in the pipeline. This goal will save time and money in the development of important drugs and not only benefit EU pharmaceutical companies but patient’s right across Europe. This is the first and final technical report for this project, as the programme was terminated 8 weeks after commencement following the resignation of the Fellow. Overall, the workprogramme proceeded according to schedule; Initial work to begin production of standard microcavity arrays was carried out. The fellow was provided with training on the preparation of the cavity arrays and had begun to prepare the arrays independently. These were to form the basis for the subsequent plasmonically directed arrays, an essential component of this project and a significant step forward in the current state-of-the-art. The fellow also spent the latter four weeks learning to use COMSOL and had commenced the computational studies to investigate where the plasmonic fields would be strongest and nanoparticle growth would occur under irradiation in the cavity structures. Initial theoretical investigation of the effect of metallic structures would have on the subsequent field enhancements was also commenced. This was an essential part of the work to inform future experiments. The computational studies had started to yield useful insights into predicted positioning and shapes of the plasmonically directed structures. Additionally, the control of; polarization, illumination direction and illumination properties such as wavelength etc. within the software indicated potential control that can be gained over the plasmonically directed structures when careful control is exerted over the illumination source used for the growth of these structures. The expected final result was the production of an optimised microcavity array with additional plasmonic features that allow the positional control of the enhancement field and thus produce a more active array (with respect to field enhancements) for the study of drug-membrane interactions that can be monitored by enhanced optical vibrational spectroscopy. 2. Project Objectives For The Period Objectives for months 0-2 as set out in the proposed work plan included the preparation of conventional cavity arrays. The first deliverable; preparation of a range of gold and gold over silver microcavity arrays with and without plasmonically directed nanostructures over the whole array and only within the cavities, was not due for completion until month eight. However, work towards this larger deliverable was on schedule within this reporting period. 3. Work Progress and Achievements During The Period • Progress towards objectives The fellow was given detailed instruction on the preparation of the conventional cavity arrays and had started to work on their production independently. He spent the first three weeks reading the literature, and enlarging on his workplan and ordering materials for the plasmonically grown structures. To aid the initial and subsequent objectives he also learnt how to use the modelling environment COMSOL and studied the effect of different cavity geometries and illumination parameters on the structures that can be expected to be plasmonically grown in different setups. This has provided numerous promising leads and will hopefully minimise the trial and error experiments that would be required to identify suitable parameters for the growth of different structural motifs on the standard microcavity arrays. • Researcher training activities The majority of Iains short time with our group was spent studying, i.e. to update and familiarise himself with the current state of the art and receiving in-house training on cavity preparation. He was also provided with initial training on some of the spectroscopic instrumentation required for the project. The Fellow also learnt how to model in the multiphysics environment of COMSOL. He started from a position of never having used this software before but got to grips with it quite quickly and managed to start to produce some useful insights which would have been used in objectives and deliverables within the overall research project, had the project continued. • Resources With respect to use of resources and researcher-months the time spent on the project has been closely aligned to the proposed plan. 4. Additional Information The fellow resigned his fellowship approximately 4 weeks into the programme. He left to take up a permanent post in the UK. Dissemination Activities N/A 5. Project Management The project was managed according to the workprogramme with biweekly meetings and additional individual planning meetings between supervisor and fellow.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The proposed research programme will advance the state of the art in nanostructured array preparation. This will be achieved by utilising microcavity arrays generated via standard nanosphere lithographic approaches and reproducibly introducing additional nanostructures via plasmonically directed growth. The resulting arrays will lead to greater optical signal enhancement due to the additional plasmonic coupling and focusing generated by the extra metallic structures. Importantly, these arrays will not only lead to increased plasmonic activity but will be reproducibly prepared, unlike current approaches used to enhance the activity of microcavity arrays.Nanostructured arrays of this nature can be used to enhance optical signals such as those generated in Raman and fluorescence spectroscopy. Therefore, following their development they will be used in the preparation of a novel drug permeability assay. Biomimetic lipid bilayers, representing natural cell membranes, will be supported on the arrays and the interaction of drug molecules of interest monitored via metal enhanced fluorescence, surface enhanced Raman spectroscopy and electrochemical impedance.The proposed approach will result in the measurement of a dissociation constant for specific drug-membrane combinations. This dissociation constant will be an improved parameter compared to the currently utilised partition coefficient that is measured for drugs between two immiscible liquids. An improved insight into drug-membrane interactions, such as those provided by the proposed novel drug permeability assay, will have significant impacts in the cosmetics and pharmaceutical fields. Product development will be better informed at a much earlier stage and only the most promising targets advanced to the more expensive in vitro and in vivo testing stages. This will ensure products are successfully brought to market quicker than currently happens and savings are made within the development pipeline.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз